DEFERASIROX

作品数:17被引量:34H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:段相林樊玉梅更多>>
相关机构:诺华股份有限公司诺瓦提斯公司台湾大学河北师范大学更多>>
相关期刊:《Case Reports in Clinical Medicine》《国外药讯》《World Journal of Hepatology》《世界临床药物》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals withβ-thalassemia major
《World Journal of Otorhinolaryngology-Head and Neck Surgery》2024年第4期309-314,共6页Balwinder S.Tiwana Ankita Aggarwal Sanjeev Bhagat Harjinder Singh Dimple Sahni Vishav Yadav 
Objective:Our study aimed to investigate the ototoxicity associated with the iron chelator deferasirox in patients withβ-thalassemia major,who were receiving regular transfusion therapy,along with evaluating the data...
关键词:AUDITORY DEFERASIROX distortion product otoacoustic emissions ORAL CHELATING agent pure tone AUDIOMETRY THALASSEMIA 
Perforated duodenal ulcer secondary to deferasirox use in a child successfully managed with laparoscopic drainage:A case report
《World Journal of Clinical Cases》2022年第34期12775-12780,共6页Abdullah Alshehri Tuqa Adil Alsinan 
BACKGROUND A perforated gastroduodenal ulcer is rarely observed in children.Certain medications have been reported to cause ulcerations.Deferasirox,an iron chelating agent,has been previously reported to be associated...
关键词:Peptic ulcer Iron chelating agents DEFERASIROX HEMOGLOBINOPATHIES CHILDREN Case report 
The synthesis and antibacterial activity evaluation of oxazolidinone-deferasirox conjugates被引量:1
《Journal of Chinese Pharmaceutical Sciences》2022年第12期946-952,共7页Xintong Zhao Yuhua Hu Tong Qin Tianlei Li Wenxuan Zhang Song Wu 
The CAMS Innovation Fund for Medical Sciences(CIFMS 2021-I2M-1-028).
We reported herein the synthesis and antibacterial activity evaluation of two oxazolidinone-deferasirox conjugates with different linkers that were designed based on the“Trojan horse”strategy.The conjugates could co...
关键词:OXAZOLIDINONE DEFERASIROX ANTIBACTERIAL SIDEROPHORE “Trojan horse”strategy 
Determination of deferasirox particle size distribution via laser diffraction and its application in establishing a correlation between particle size and drug dissolution in vitro被引量:2
《Journal of Chinese Pharmaceutical Sciences》2021年第11期912-923,共12页Yuyuan Chen Song Wu Liqing Chen Yuanyuan Zhang Zhonggao Gao Tianlei Li Wei Huang Qingyun Yang 
CAMS Innovation Fund for Medical Sciences(CIFMS No.2016-I2M-3-010 and CIFMS No.2017-I2M-1-011)。
Deferasirox is the first-line drug for iron overload due to thalassemia in adults and pediatric patients. It is classified as a type II compound in the Biopharmaceutics Classification System, and thus the particle siz...
关键词:DEFERASIROX Particle size distribution Laser diffraction Dissolution curve 
Chelation therapy in liver diseases of childhood: Current status and response被引量:1
《World Journal of Hepatology》2021年第11期1552-1567,共16页Jayendra Seetharaman Moinak Sen Sarma 
Chelation is the mainstay of therapy in certain pediatric liver diseases.Copper and iron related disorders require chelation.Wilson’s disease(WD),one of the common causes of cirrhosis in children is treated primarily...
关键词:Wilson’s disease D-PENICILLAMINE Trientine Indian childhood cirrhosis DEFEROXAMINE DEFERASIROX HEMOCHROMATOSIS 
Juvenile hemochromatosis:HAMP mutation and severe iron overload treated with phlebotomies and deferasirox被引量:2
《World Journal of Clinical Cases》2017年第10期381-383,共3页Manuel A Lescano Letícia C Tavares Paulo C J L Santos 
Juvenile hemochromatosis(JH) is a rare condition classified as an autosomal recessive disorder that leads to severe iron absorption. JH usually affects people under the age of 30 and presents symptoms such as chronic ...
关键词:Genetic disease Juvenile hemochromatosis HAMP gene MUTATION Iron chelation 
Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma被引量:3
《World Journal of Gastroenterology》2016年第40期8967-8977,共11页Issei Saeki Naoki Yamamoto Takahiro Yamasaki Taro Takami Masaki Maeda Koichi Fujisawa Takuya Iwamoto Toshihiko Matsumoto Isao Hidaka Tsuyoshi Ishikawa Koichi Uchida Kenji Tani Isao Sakaida 
Supported by Grants-in-Aid for Scientific Research from the Japan Society for the Program of Science,No.23590978 and No.16H05287;the Strategic Research Promotion Program from Yamaguchi University
AIM To evaluate the inhibitory effects of deferasirox(DFX) against hepatocellular carcinoma(HCC) through basic and clinical studies.METHODS In the basic study, the effect of DFX was investigated in three hepatoma cell...
关键词:Liver tumor Hepatocellular carcinoma Advanced stage Iron-chelator DEFERASIROX 
New developments and controversies in iron metabolism and iron chelation therapy被引量:5
《World Journal of Methodology》2016年第1期1-19,共19页Christina N Kontoghiorghe George J Kontoghiorghes 
Iron is essential for all organisms including microbial,cancer and human cells. More than a quarter of the human population is affected by abnormalities of iron metabolism, mainly from iron deficiency and iron overloa...
关键词:IRON metabolism IRON CHELATION therapy DEFERIPRONE DEFEROXAMINE DEFERASIROX IRON diseases Medical journals CONTROVERSIES 
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients被引量:1
《World Journal of Methodology》2014年第3期163-188,共26页Christina N Kontoghiorghe Nicholas Andreou Katerina Constantinou George J Kontoghiorghes 
According to global annual estimates hunger/malnutrition is the major cause of death(36 of 62 million). Cardiovascular diseases and cancer(5.44 of 13.43 million) are the major causes of death in developed countries, w...
关键词:World health issues Global DISEASES Orphandrugs ORPHAN DISEASES Rare DISEASES ORPHAN PATIENTS THALASSAEMIA DEFERIPRONE DEFERASIROX Deferoxamine Iron overload 
Low Level Determination of Genotoxic Impurity in Deferasirox Formulation
《Journal of Analytical Sciences, Methods and Instrumentation》2013年第4期179-183,共5页Pravish Kumar Tiwari Padmakar Sathe Navin Devadiga 
4-hydrazinobenzoic acid has been highlighted as one of the potential genotoxic impurities (PGIs). A sensitive HPLC method was developed and validated for the determination of 4-hydrazino benzoic acid in Deferasirox Ta...
关键词:DEFERASIROX GENOTOXIC 4-Hydrazinobenzoic ACID HPLC 
检索报告 对象比较 聚类工具 使用帮助 返回顶部